All articles tagged: Malignant neoplasm of unspecified part of unspecified bronchus or lung (C34.90)

Intensity-modulated radiotherapy (IMRT) is recommended for locally advanced non-small cell lung cancer (NSCLC) and appears to have good long-term outcomes, according to a study published online June 27 in JAMA Oncology.Stephen G. Chun, M.D., from The University of Texas MD Anderson Cancer Center in Houston, and colleagues compared long-

Electronic cigarette use is associated with a lower use of lung cancer screening (LCS), according to a research letter published online July 2 in JAMA Network Open.Qian Wang, M.D., M.P.H., from the University Hospitals Seidman Cancer Center in Cleveland, and colleagues examined the association between e-cigarette use and LCS uptake in a

For patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC), amivantamab-lazertinib yields improved progression-free survival compared with osimertinib as first-line treatment, according to a study published online June 26 in the New England Journal of Medicine.Byoung C. Cho, M.D., Ph.D., from the Yonsei Cancer Ce

The overall prevalence of up-to-date (UTD) lung cancer screening (LCS) was low in 2022, with prevalence increasing with age and number of comorbidities, according to a study published online June 10 in JAMA Internal Medicine.Priti Bandi, Ph.D., from the American Cancer Society in Atlanta, and colleagues estimated the contemporary preval

Younger adults are experiencing increased cancer rates, possibly linked to accelerated biological aging. Researchers analyzed data from the UK Biobank, finding associations between faster aging and higher cancer risks. This study suggests potential for targeted screenings and interventions based on accelerated aging markers to mitigate cancer risks in younger individuals.

Metformin, a frontline treatment for type 2 diabetes, has long been a pharmaceutical mainstay, with over 91 million prescriptions in 2021 alone. However, recent evidence suggests that metformin's efficacy extends beyond diabetes management, encompassing various conditions such as cancer, obesity, liver disease, cardiovascular issues, neurodegenerative disorders, and renal diseases. As research exp

Toby Keith, a beloved figure in the country music scene, has recently passed away, leaving fans and the music industry in mourning. However, his death has also brought attention to an important health issue: stomach cancer. In this article, we’ll delve into the details of stomach cancer, Toby Keith’s battle with the disease, and what can be learned from his experience.

Following a recall of millions of its breathing machines that began in mid-2021, Philips Respironics announced Monday that it would halt sales of all such machines within the United States.The machines include continuous positive airway pressure (CPAP) devices used by people with sleep apnea, as well as ventilators used by other patients. <p

For percutaneous lung ablation, high-frequency jet ventilation (HFJV) under general anesthesia seems as safe as spontaneous respiration (SR) under moderate sedation, with longer room time for HFJV, according to a study published online Jan. 24 in the American Journal of Roentgenology.Alexander Graur, from Massachusetts General Hospital

From 2000 to 2020, U.S. age-adjusted cancer mortality rates decreased significantly, but racial and ethnic disparities persisted for certain cancers, according to a research letter published online Jan. 12 in JAMA Health Forum.Anjali Gupta and Tomi Akinyemiju, Ph.D., from the Duke University School of Medicine in Durham, North Carolin

Chemoradiation with an adaptive stereotactic ablative radiotherapy (SABR) boost is safe and effective for patients with locally advanced, unresectable non–small cell lung cancer (NSCLC), according to a study published online Jan. 11 in JAMA Oncology.Trudy C. Wu, M.D., from the University of California in Los Angeles, and colleagues exa

Initiation of immunotherapy for metastatic cancer at the end of life (EOL) is increasing over time, according to a study published online Jan. 4 in&nbsp;JAMA Oncology.Daniel M. Kerekes, M.D., from Yale University in New Haven, Connecticut, and colleagues examined patient characteristics, practice patterns, and risk factors concerning

For individuals undergoing low-dose computed tomography (LDCT) scans for lung cancer screening (LCS), the rates of downstream procedures and complications are higher than observed in the National Lung Screening Trial (NLST), according to a study published online Jan. 2 in the Annals of Internal Medicine.Katharine A. Rendle, Ph.D., M.P.H

The NPR article reports elevated levels of the carcinogen chromium-6 in wildfire ash, potentially posing health risks like lung cancer due to inhalation. Researchers call for further investigation and protective measures in affected areas.

Outdoor air pollution is tied to a higher risk for nonlung cancers in older adults, according to a study published online Aug. 1 in Environmental Epidemiology.Yaguang Wei, Ph.D., from the Harvard T.H. Chan School of Public Health in Boston, and colleagues examined associations of 10-year exposures to fine particulate matter (PM2.

For patients with metastatic non-small cell lung cancer (NSCLC) receiving immunotherapy, outcomes are similar across racial and ethnic groups, but ECOG performance status (PS) is associated with survival, according to a study published online Dec. 11 in the Journal of the National Comprehensive Cancer Network.Matthew Lee, M.D., M.P.H

Increasing body mass index (BMI) at age 18 years is associated with development of subsequent site-specific cancers in men, according to a study published online Nov. 6 in&nbsp;Obesity.Aron Onerup, M.D., Ph.D., from the University of Gothenburg in Sweden, and colleagues examined BMI at age 18 years and incident site-specific cancer (

The annual meeting of the Radiological Society of North America was held from Nov. 26 to 30 in Chicago, drawing nearly 25,000 participants, including radiologists, radiation oncologists, physicists in medicine, radiologic technologists, and other health care professionals. The conference featured scientific papers from a number of subspecialtie

For patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC), osimertinib with chemotherapy leads to significantly longer progression-free survival (PFS) compared with osimertinib alone, according to a study published online Nov. 8 in the New England Journal of Medicine.David Planchard, M.D., Ph.D., from Institu

The rate of new lung cancer cases has decreased and survival has improved over the last five years, according to the State of Lung Cancer 2023 report published Nov. 14 by the American Lung Association.In the report, researchers present the latest national and state-by-state lung cancer data, including new cases, survival, early diagnosis, and s

In a guideline update issued by the American Cancer Society and published online Nov. 1 in CA: A Cancer Journal for Clinicians, the authors recommend increasing eligibility for lung cancer screening (LCS).Andrew M.D. Wolf, M.D., from the University of Virginia School of Medicine in Charlottesville, and colleagues updated the American C

A study by the Ontario Institute for Cancer Research links tobacco smoking to DNA mutations that disrupt cancer-fighting proteins, increasing cancer risk and complicating treatment. The more one smokes, the more mutations occur, particularly in lung cancer, highlighting smoking's severe impact on cellular health and cancer development.

The American Cancer Society has updated its lung cancer screening guidelines to include adults aged 50-80 with a significant smoking history, regardless of how long ago they quit. This expansion could prevent 21% more lung cancer deaths and is aimed at improving early detection, especially in high-risk communities.

The annual meeting of the American College of Chest Physicians was held this year from Oct. 8 to 11 in Honolulu and attracted participants from around the world, including specialists and heath care professionals focused on pulmonary medicine, critical care, and sleep medicine. The conference feat